A Phase 1 clinical trial that will evaluate the Boost-2867 #covid #COVID19 booster administered via nasal spray is now recruiting in Seattle, at Kaiser's research institute. You don't need to be a Kaiser member to be in the study. The study is also recruiting in five other places in the US, some of which will be testing a jab version instead of a nasal spray version.

Details are at: https://www.kpwhri.org/news-and-events/recent-news/news-2026/researchers-begin-trial-nasal-spray-COVID-19-vaccine and https://clinicaltrials.gov/study/NCT07221162